

Most Read This Week
- Semaglutide and Cardiovascular Outcomes in Patients With Obesity Without Diabetes
- Stroke and Bleeding Risk in Patients With Atrial Fibrillation and a CHA2DS2-VASc Risk Score of 1
- Apixaban for Stroke Prevention in Patients With Subclinical Atrial Fibrillation
- Association of Daily Step Counts With All-Cause Mortality and Cardiovascular Events
- Device-Measured Physical Activity and Cardiometabolic Health
Recently Updated
- Cardiac Rehabilitation Use Low in Distressed Communities
- Coronary Heart Disease, Especially With Early Onset, Linked to Dementia
- DOACs for Stroke Prevention in Patients With Device-Detected Atrial Fibrillation
- Stroke and Bleeding Risk in Patients With Atrial Fibrillation and a CHA2DS2-VASc Risk Score of 1
- Clinical Outcomes of Tongxinluo Therapy in Patients With Acute Myocardial Infarction